News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
637,353 Results
Type
Article (45069)
Company Profile (342)
Press Release (591930)
Multimedia
Podcasts (121)
Webinars (21)
Section
Business (172312)
Career Advice (2474)
Deals (31462)
Drug Delivery (127)
Drug Development (80009)
Employer Resources (148)
FDA (15139)
Job Trends (13222)
News (304427)
Policy (29560)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2721)
Academic (1)
Accelerated approval (42)
Adcomms (32)
Allergies (165)
Alliances (44719)
ALS (204)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (396)
Approvals (15409)
Artificial intelligence (609)
Autoimmune disease (230)
Automation (43)
Bankruptcy (329)
Best Places to Work (10716)
BIOSECURE Act (17)
Biosimilars (195)
Biotechnology (258)
Bladder cancer (181)
Brain cancer (68)
Breast cancer (693)
Cancer (5391)
Cardiovascular disease (464)
Career advice (2104)
Career pathing (42)
CAR-T (312)
CDC (54)
Cell therapy (840)
Cervical cancer (37)
Clinical research (68840)
Collaboration (1917)
Company closure (5)
Compensation (941)
Complete response letters (82)
COVID-19 (2713)
CRISPR (108)
C-suite (1024)
Cystic fibrosis (153)
Data (7074)
Decentralized trials (3)
Denatured (27)
Depression (168)
Dermatology (57)
Diabetes (549)
Diagnostics (6354)
Digital health (43)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (310)
Drug pricing (194)
Drug shortages (25)
Duchenne muscular dystrophy (282)
Earnings (67361)
Editorial (62)
Employer branding (20)
Employer resources (140)
Events (96928)
Executive appointments (1071)
FDA (18485)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1584)
Gene editing (229)
Generative AI (56)
Gene therapy (712)
GLP-1 (1068)
Government (4570)
Grass and pollen (7)
Guidances (392)
Healthcare (17450)
HIV (74)
Huntington's disease (55)
IgA nephropathy (95)
Immunology and inflammation (305)
Immuno-oncology (85)
Indications (154)
Infectious disease (3028)
Inflammatory bowel disease (216)
Inflation Reduction Act (16)
Influenza (128)
Intellectual property (274)
Interviews (528)
IPO (14580)
IRA (53)
Job creations (2853)
Job search strategy (1694)
JPM (67)
Kidney cancer (20)
Labor market (69)
Layoffs (562)
Leadership (42)
Legal (6438)
Liver cancer (101)
Longevity (24)
Lung cancer (738)
Lymphoma (403)
Machine learning (50)
Management (52)
Manufacturing (865)
MASH (193)
Medical device (11768)
Medtech (11832)
Mergers & acquisitions (17992)
Metabolic disorders (1458)
mRNA (191)
Multiple sclerosis (172)
NASH (24)
Neurodegenerative disease (410)
Neuropsychiatric disorders (111)
Neuroscience (3284)
Neurotech (1)
NextGen: Class of 2026 (6019)
Non-profit (4172)
Now hiring (68)
Obesity (687)
Opinion (306)
Ovarian cancer (186)
Pain (231)
Pancreatic cancer (257)
Parkinson's disease (353)
Partnered (33)
Patents (547)
Patient recruitment (594)
Peanut (62)
People (56758)
Pharmaceutical (50)
Pharmacy benefit managers (23)
Phase 1 (21580)
Phase 2 (30348)
Phase 3 (22652)
Pipeline (7033)
Policy (308)
Postmarket research (2439)
Preclinical (9114)
Press Release (61)
Prostate cancer (277)
Psychedelics (57)
Radiopharmaceuticals (318)
Rare diseases (1054)
Real estate (4712)
Recruiting (64)
Regulatory (23469)
Reports (31)
Research institute (2365)
Resumes & cover letters (363)
Rett syndrome (33)
RNA editing (22)
RSV (80)
Schizophrenia (175)
Series A (268)
Series B (204)
Service/supplier (3)
Sickle cell disease (111)
Special edition (23)
Spinal muscular atrophy (172)
Sponsored (41)
Startups (3319)
State (2)
Stomach cancer (19)
Supply chain (104)
Tariffs (76)
The Weekly (92)
Vaccines (1049)
Venture capital (105)
Weight loss (453)
Women's health (92)
Worklife (19)
Date
Last 7 days (616)
Last 30 days (2372)
Last 365 days (28922)
2026 (7671)
2025 (29231)
2024 (33841)
2023 (37786)
2022 (48746)
2021 (52437)
2020 (50460)
2019 (42915)
2018 (32376)
2017 (30046)
2016 (28662)
2015 (33690)
2014 (26198)
2013 (21342)
2012 (22468)
2011 (23374)
2010 (21146)
Location
Africa (778)
Alabama (90)
Alaska (4)
Arizona (259)
Arkansas (13)
Asia (42843)
Australia (7694)
California (11360)
Canada (3401)
China (1251)
Colorado (477)
Connecticut (462)
Delaware (363)
Europe (88166)
Florida (1729)
Georgia (353)
Hawaii (3)
Idaho (60)
Illinois (875)
India (79)
Indiana (496)
Iowa (18)
Japan (494)
Kansas (121)
Kentucky (38)
Louisiana (39)
Maine (62)
Maryland (1403)
Massachusetts (8322)
Michigan (313)
Minnesota (607)
Mississippi (6)
Missouri (133)
Montana (29)
Nebraska (25)
Nevada (124)
New Hampshire (81)
New Jersey (3165)
New Mexico (26)
New York (3020)
North Carolina (1473)
North Dakota (7)
Northern California (5509)
Ohio (322)
Oklahoma (18)
Oregon (38)
Pennsylvania (2282)
Puerto Rico (25)
Rhode Island (44)
South America (1048)
South Carolina (71)
South Dakota (1)
Southern California (4575)
Tennessee (175)
Texas (1819)
United States (40563)
Utah (353)
Vermont (1)
Virginia (264)
Washington D.C. (71)
Washington State (935)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
637,353 Results for "repregen ltd formerly known as bioceramic therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Pharmaceuticals Ltd’s Annual Report 2025 Published
March 4, 2026
·
4 min read
Press Releases
Faron Pharmaceuticals Ltd: Director Dealing
March 19, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Results of the Extraordinary General Meeting
March 2, 2026
·
5 min read
Press Releases
Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
March 5, 2026
·
3 min read
Press Releases
CORRECTION: Faron Pharmaceuticals Ltd’s Annual Report 2025 published
March 5, 2026
·
4 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
·
3 min read
Press Releases
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment
December 3, 2025
·
4 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Upcoming December 2025 Investor Conference
December 3, 2025
·
1 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)
March 25, 2026
·
2 min read
Previous
2 of 63,736
Next
